Skip to search formSkip to main contentSkip to account menu

Abbokinase

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Urokinase
Urokinase 50000 UNT/ML Injectable Solution [Abbokinase]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Intra-arterial thrombolysis in acute ischemic stroke: a review of pharmacologic approaches
Ischemic stroke is a major public health problem worldwide. The potential to cure stroke patients with intravenous thrombolytic… 
2002
2002
FDA approves reintroduction of `Abbokinase'
  • 2002
  • Corpus ID: 195119346
2000
2000
The case of Abbokinase and the FDA: the events leading to the suspension of Abbokinase supplies in the United States.
2000
2000
The case of Abbokinase and the FDA: the events leading to the suspension of Abbokinase supplies in the US, G.G. Harnell, J. Gates, in: SCVIR, 11. (2000), 841
1999
1999
Warning on Abbokinase
1999
1999
Update on Abbokinase (Urokinase)
1992
1992
A-chain isozymes of recombinant and natural urokinases: Preparation, characterization, and their biochemical and fibrinolytic properties
1990
1990
Reduction of disulfides in urokinase and insertion of a synthetic peptide.
1989
1989
Treatment of sudden deafness with Abbokinase.
We studied the therapeutic effect of high-dose administration of a thrombolytic agent (Abbokinase®) in 33 patients with sudden… 
1987
1987
Clot lysis for thrombosed central venous catheters in pediatric patients.
Central venous catheters (CVC) in pediatric patients provide a reliable method for administration of total parenteral nutrition… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)